An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
It is a randomized, double-blind, multi-center, two-arm study intended to assess the safety
and efficacy of three different doses/dose regimens of paromomycin administered
intramuscularly as follows: 11 mg/kg/day for 14 days and 11 mg/kg/day for 21 days for the
treatment of visceral leishmaniasis (VL) in India.